Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — Sphera Biotech US Fund, L.P.

0001749475-26-000001 · filed Apr 27, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings

Offering

Industry
Pooled Investment Fund
Exemptions
Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(7)
Reported offering amount
—
Reported amount sold
$32,071,088
Minimum investment
$500,000
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Sphera Biotech US Fund, L.P.
CIK
1749475
Entity
Limited Partnership
Jurisdiction
DELAWARE
Year incorporated
—
Address
SPHERA GLOBAL HEALTHCARE MANAGEMENT, LP
TEL AVIV, Israel 6777520
Phone
972-3-6845535

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗